FDA Inspection
Merck & Co. IncMerck & Co. Inc – FDA Inspection, Dec 18, 2025
Record Details
This FDA Inspection record concerns Merck & Co. Inc, with an inspection on December 18, 2025, issued by the New Jersey District Office, covering biologics.
View Company Profile
ID · 3db085e5-9756-4923-a078-ed1c7815373b
Inspection Facts
- Inspection number
- 1283890
- FDA center
- Biologics
Other FDA inspections of Merck & Co. Inc
15| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | Not classified | New Jersey District Office | |
| March 13, 2026 | Not classified | New Jersey District Office | |
| May 16, 2025 | Not classified | New Jersey District Office | |
| March 27, 2025 | Not classified | New Jersey District Office | |
| November 18, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck & Co. Inc
- FDA Inspection 1329118 - 2026-08-14
- FDA Inspection 1305632 - 2026-03-13
- FDA Inspection 1262774 - 2025-05-16
- FDA Inspection 1264192 - 2025-03-27
- FDA Inspection 1158317 - 2021-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.